Table of Contents

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
     
þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2008
     
o   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM  _____  TO  _____ 
Commission file number 333-145939
CLEANTECH BIOFUELS, INC.
(Exact name of registrant as specified in its charter)
     
Delaware
(State or other jurisdiction of incorporation or organization)
  33-0754902
(I.R.S. Employer Identification No.)
     
7386 Pershing Ave., University City, Missouri
(Address of principal executive offices)
  63130
(Zip Code)
(Registrant’s telephone number): (314) 802-8670
Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES þ NO o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
             
Large accelerated filer o   Accelerated filer o   Non-accelerated filer o   Smaller reporting company þ
        (Do not check if a smaller reporting company)    
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No þ
As of August 13, 2008, 58,232,591 shares of the Company’s common stock were outstanding.
 
 

 

 


 

CLEANTECH BIOFUELS, INC.
TABLE OF CONTENTS
         
    PAGE  
 
       
       
 
       
       
 
       
    3  
 
       
    4  
 
       
    5  
 
       
    6  
 
       
    7  
 
       
    12  
 
       
    18  
 
       
    18  
 
       
       
 
       
    19  
 
       
    19  
 
       
    20  
 
       
    20  
 
       
    20  
 
       
    20  
 
       
    20  
 
       
    21  
 
       
    22  
 
       
  Exhibit 2.1
  Exhibit 31.1
  Exhibit 31.2
  Exhibit 32.1
  Exhibit 32.2

 

2


Table of Contents

PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
BALANCE SHEETS
                 
    June 30,     December 31,  
    2008     2007  
    (unaudited)          
ASSETS
Current assets:
               
Cash and cash equivalents
  $ 43,092     $ 120,356  
Receivables:
               
Interest
          19,425  
Promissory notes
          450,000  
Prepaids and other current assets
    49,565       72,026  
 
           
 
    92,657       661,807  
 
               
Property and equipment, net
    31,101       3,099  
 
               
Non-current asset:
               
Technology license, net
    105,000       112,500  
 
           
Total Assets
  $ 228,758     $ 777,406  
 
           
 
               
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
               
Accounts payable
  $ 127,317     $ 91,988  
Accrued interest
    10,290       60,433  
Accrued professional fees
    36,600       36,600  
Capital Lease
    4,930        
 
           
Total current liabilities
    179,137       189,021  
 
               
Capital Lease
    8,085        
Series A Convertible Debentures
    140,000       1,400,000  
 
               
STOCKHOLDERS’ DEFICIT
Preferred stock, $0.001 par value; 10,000,000 authorized shares; no shares issued or outstanding
           
Common stock, $0.001 par value; 240,000,000 authorized shares; 58,232,591 and 49,343,680 shares issued and outstanding at June 30, 2008 and December 31, 2007, respectively
    58,233       49,344  
Additional paid-in capital
    2,847,019       364,260  
Notes receivable — restricted common shares issued to Directors
    (90,000 )     (90,000 )
Deficit accumulated during the development stage
    (2,913,716 )     (1,135,219 )
 
           
Total Stockholders’ Deficit
    (98,464 )     (811,615 )
 
           
Total Liabilities and Stockholders’ Deficit
  $ 228,758     $ 777,406  
 
           
See accompanying notes to financial statements.

 

3


Table of Contents

CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
STATEMENTS OF OPERATIONS (Unaudited)
                                         
                                    July 14, 2004  
    Three months ended     Six months ended     (inception) to  
    June 30     June 30     June 30,  
    2008     2007     2008     2007     2008  
Costs and expenses:
                                       
General and administrative
  $ 675,819     $ 229,344     $ 1,325,281     $ 233,351     $ 1,824,916  
Professional fees
    78,946       154,873       190,892       156,843       519,535  
Research and development
    53,812             236,916             369,146  
 
                             
 
    808,577       384,217       1,753,089       390,194       2,713,597  
 
                                       
Other expense (income):
                                       
Interest
    4,136       17,500       23,887       21,097       90,655  
Amortization of technology license
    3,750             7,500             27,500  
Deposit forfeiture
                            (25,000 )
Interest income
    (252 )     (5,020 )     (5,979 )     (5,020 )     (27,384 )
 
                             
 
    7,634       12,480       25,408       16,077       65,771  
 
                             
 
                                       
Net loss applicable to common stockholders
  $ 816,211     $ 396,697     $ 1,778,497     $ 406,271     $ 2,779,368  
 
                             
 
                                       
Basic and diluted net loss per common share
  $ 0.01     $ 0.01     $ 0.03     $ 0.01     $ 0.06  
 
                             
 
                                       
Weighted average common shares outstanding
    57,489,950       43,684,232       53,786,237       41,154,508       44,983,720  
 
                             
See accompanying notes to financial statements .

 

4


Table of Contents

CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
Statements of Changes in Stockholders’ Deficit (unaudited)
                                         
                            Notes Rec -        
                            restricted        
                            common     July 14, 2004  
                    Additional     shares     (inception) to  
    Common Stock     Paid-in     issued to     June 30,  
    Shares     Amount     Capital     Directors     2008  
 
                                       
Balances at December 31, 2007
    49,343,680     $ 49,344     $ 364,260     $ (90,000 )   $ (1,135,219 )
 
Conversion of promissory notes in March 2008 at $.15 per share
    4,433,067       4,433       660,527                  
Conversion of promissory notes in April 2008 at $.15 per share
    4,455,844       4,456       663,921                  
Stock-based compensation
                    1,158,311                  
Net loss
                                    (1,778,497 )
 
                             
Balances at June 30, 2008
    58,232,591     $ 58,233     $ 2,847,019     $ (90,000 )   $ (2,913,716 )
 
                             
See accompanying notes to financial statements.

 

5


Table of Contents

CLEANTECH BIOFUELS, INC.
(formerly Alternative Ethanol Technologies, Inc.)
(A Development Stage Company)
STATEMENTS OF CASH FLOWS (Unaudited)
                         
                    July 14, 2004  
    For the six months ended     (inception) to  
    June 30,     June 30,  
    2008     2007     2008  
OPERATING ACTIVITIES
                       
Net loss applicable to common stockholders
  $ (1,778,497 )   $ (406,271 )   $ (2,779,368 )
Adjustments to reconcile net loss applicable to common stockholders to net cash used by operating activities:
                       
Common stock issued for organizational costs
                100  
Amortization
    7,500             27,500  
Depreciation
    12,796             13,052  
Share-based compensation expense
    1,158,311             1,197,440  
Fair value of RAM warrant settlement
                125,027  
Changes in operating assets and liabilities:
                       
Interest receivable
    (5,475 )     (4,375 )     (24,900 )
Prepaids and other current assets
    22,461             (49,565 )
Technology license
          (15,000 )     (132,500 )
Accounts payable
    35,329             127,317  
Accrued interest
    23,194       15,061       83,627  
Accrued liabilities
          14,496       36,600  
 
                 
Cash used by operating activities
    (524,381 )     (396,089 )     (1,375,670 )
 
                       
INVESTING ACTIVITIES
                       
Expenditures for equipment
    (40,798 )           (44,153 )
 
                 
Cash used by investing activities
    (40,798 )           (44,153 )
 
                       
FINANCING ACTIVITIES
                       
Advances — related parties
          (110,957 )      
Capital lease
    13,015             13,015  
Series A Convertible Debentures
    474,900       950,000       1,424,900  
Sale of common stock
                25,000  
 
                 
Cash provided by financing activities
    487,915       839,043       1,462,915  
 
                 
(Decrease) increase in cash and cash equivalents
    (77,264 )     442,954       43,092  
Cash and cash equivalents at beginning of period
    120,356       20        
 
                 
Cash and cash equivalents at end of period
  $ 43,092     $ 442,974     $ 43,092  
 
                 
 
                       
Supplemental disclosure of cash flow information:
                       
Cash paid for interest
  $     $     $ 6,334  
 
                 
 
                       
Supplemental disclosure of noncash investing and financing activities:
                       
Promissory notes receivable
  $     $ 450,000     $ 450,000  
 
                 
Series A Convertible Debentures
  $     $ 450,000     $ 450,000  
 
                 
Restricted common stock issued to Directors
  $     $     $ 90,000  
 
                 
Common stock issued for organizational costs
  $     $     $ 100  
 
                 
Common stock issued for promissory notes
  $     $     $ 133,596  
 
                 
Common stock issued for Debentures converted
  $ 1,333,337     $     $ 1,333,337  
 
                 
See accompanying notes to financial statements.

 

6


Table of Contents

Note 1 — Organization and Business
Alternative Ethanol Technologies, Inc. (the “Company”), was incorporated in Delaware on December 20, 1996. Effective August 2, 2007, the Company changed its name to CleanTech Biofuels, Inc.
On March 27, 2007, the Company acquired SRS Energy, Inc., a Delaware corporation (“SRS Energy”), pursuant to an Agreement and Plan of Merger and Reorganization. In accordance with the merger agreement, SRS Acquisition Sub, Inc., a Delaware corporation and wholly-owned subsidiary of the Company, merged with and into SRS Energy. The merger was consummated on May 31, 2007 and resulted in SRS Energy becoming a wholly-owned subsidiary of the Company. As a result of the merger, the stockholders of SRS Energy surrendered all of their issued and outstanding common stock and received shares of the Company’s $.001 par value common stock. The former parent of SRS Energy, Supercritical Recovery Systems, Inc., immediately prior to the merger, distributed 78.8% of its 96% ownership in SRS Energy to its shareholders on a pro rata basis.
For accounting purposes, because the Company had been a public shell company prior to the merger, the merger was treated as an acquisition of the Company and a recapitalization of SRS Energy. As a result, the historical information of the Company prior to the merger disclosed in this report is that of SRS Energy. In addition, historical share amounts have been restated to reflect the effect of the merger.
The Company is a development stage company that has been engaged in technology development and pre-operational activities since its formation. Its business strategy is to develop, own and operate renewable energy facilities with a primary focus on the conversion of cellulose feed stocks to fuel ethanol and other combustible fuels. The Company has limited exclusive licenses to technology designed to convert cellulosic feed stocks, including municipal solid waste (also referred to as MSW), into ethanol and other combustible sources of energy. The Company has no operating history as a producer of ethanol and has not constructed any ethanol plants to date. It has no revenues to date and expects that its current capital and other existing resources will be sufficient only to provide a limited amount of working capital. The Company will require substantial additional capital to implement its business plan and it may be unable to obtain the capital required to do so.
Note 2 — Interim Financial Statements
The accompanying unaudited, financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments, consisting of normal recurring items considered necessary for a fair presentation, have been included. Operating results for the three and six months ended June 30, 2008 are not necessarily indicative of the results that may be expected for the year ended December 31, 2008. For further information, refer to the Company’s audited financial statements and notes thereto included in our Annual Report on Form 10-KSB for the year ended December 31, 2007, filed with the Securities and Exchange Commission on March 28, 2008.
Note 3 — Technology Licenses
Brelsford Engineering, Inc.
On April 1, 2005, the Company entered into a license agreement with Brelsford Engineering, Inc. (“Brelsford”) giving the Company the exclusive right to use Brelsford’s technology (Patent No. 5,411,594) to convert cellulosic biomass into fuel grade ethanol in the United States. This agreement was amended in November 2005 to extend the initial evaluation period for the technology. Under the terms of the license with Brelsford, the Company paid an initial fee of $50,000 and monthly fees for the trial option premium totaling $67,500 (recorded as a long-term asset in the aggregate on the balance sheet). The Company also pays a minimum annual fee of $15,000 and a project fee of $30,000 for each project that commences for the manufacture of a plant. On August 30, 2007, the Company paid the first project fee in the amount of $30,000 to Brelsford with the respect to the commencement of the design of our pilot plant and Brelsford simultaneously acknowledged that the Company had met all requirements to maintain the exclusivity of its license. In addition, the Company will pay a royalty fee equal to 4 percent of sales resulting from use of the licensed product less any applicable taxes. Brelsford may terminate the license agreement on sixty days’ notice if the Company fails to make any payment due under our license agreement. Commencing with the first project payment, the Company began amortizing costs previously capitalized over the remaining term of the license. Amortization expense for the three and six months ended June 30, 2008 is $3,750 and $7,500, respectively. There was no amortization expense for the three and six months ended June 30, 2007. The license, issued by Brelsford, terminates simultaneously with the expiration of the patent, in May 2015.

 

7


Table of Contents

Bio-Products International, Inc.
On August 17, 2005, the Company entered into a license agreement with Bio-Products International, Inc. (“Bio-Products”) giving the Company limited exclusive rights to use Bio-Products technology (Patent No. 6,306,248) to process MSW and convert the cellulosic component of that waste to a homogenous feedstock to produce ethanol in the United States, subject to the right of Bio-Products to request five sites to construct MSW to ethanol plants in the United States. The Company’s license with Bio-Products is for a period of twenty years. Under the license, Bio-Products is paid a process royalty of $1.50 for every ton of waste received and processed at each facility to be constructed and operated under the agreement. The Company also is required to pay a by-product royalty of 2.5 percent of the gross sales price in excess of $10 per ton obtained from the sale of recyclable byproducts, excluding the cellulosic biomass. Bio-Products will also be paid a monthly fee for technical services to be provided by Bio-Products for each facility to be constructed and operated which initially will be $10,000 per month and will increase to $20,000 per month when vessels for processing waste are ordered for the facility. The $20,000 per month fee continues until construction of the facility is completed.
HFTA, Inc.
On March 20, 2008, the Company entered into a license agreement with HFTA, Inc. (“HFTA”) granting the Company the exclusive worldwide right to use the HFTA technology for the production of ethanol from MSW. The terms set out in the agreement required us to pay an initial license fee of $25,000 to HFTA on execution of the agreement and a second license fee in the amount of $150,000 on September 1, 2009 if we are using the technology at that time.
Additionally, we deposited 2,887,687 shares of our common stock into an escrow account on May 12, 2008. The shares held in escrow will be released to HFTA as follows: one-third upon completion of the proof of concept phase if at that time we elect to continue to use the HFTA technology in the demonstration phase and two-thirds upon completion of the demonstration phase if at that time we elect to incorporate the HFTA technology into the small commercial plant. For accounting purposes, the shares held in escrow are not considered issued and outstanding as the Company has the option to use or not use the technology and the shares are not deemed issued or vested until that time as described above. As of June 30, 2008, the approximate expense to be recorded upon issuing the first third of the shares, based on the market value of our common stock at June 30, 2008, would be approximately $1.1 million.
In addition, we are required to pay a process royalty of 4% of the sales price of ethanol less taxes and applicable fees if the sales price is in excess of $1.50 per gallon, 3% of the sales price if it is between $1.50 and $1.30 per gallon, and 2% of the sales price if it is less than $1.30 per gallon. We are also required to pay certain minimum royalties, less the amount of any process royalties paid, commencing in the calendar year ending December 31, 2010 and in subsequent years as follows: (i) 2010 -$25,000; (ii) 2011 — $25,000; (iii) 2012 — $60,000; (iv) increasing by $20,000 per year for each year thereafter until it reaches $120,000 per year; and (v) $120,000 per year thereafter.
All intangible assets are reviewed for impairment whenever events or other changes in circumstances indicate that the carrying amount may not be recoverable. An impairment charge is recognized if the carrying amount of an intangible asset exceeds its implied fair value.
Note 4 — Series A Convertible Debentures
In April 2007, the Company sold $1,400,000 of Series A Convertible Debentures (“Debentures”), due April 16, 2010, that convert into shares of the Company’s common stock at $.15 per share. The Company filed a registration statement with regard to the sale of these shares of common stock, which was declared effective by the Securities and Exchange Commission on January 2, 2008. The debentures accrue interest at 6% per annum. The interest is payable in cash or shares of the Company’s common stock at the Company’s option. The Debenture Holders can convert their amount into shares at any time until the due date. The maximum number of shares that would be issued at the due date is 11,013,333.

 

8


Table of Contents

The Company received cash of $950,000 and Promissory Notes (“Notes”) with an aggregate principal amount of $450,000 that accrue interest at 6.0%. Effective with the listing of our common stock on the OTCBB on March 13, 2008 (previously traded on Pink Sheets) we received full payment on all principal and accrued interest on the Notes totaling approximately $475,000 on March 14, 2008.
During March 2008, various debenture holders converted an aggregate amount of $630,000 of our Debentures, plus interest earned, into 4,433,067 shares of our common stock. During April 2008, various debenture holders converted an aggregate amount of $630,000 of our Debentures, plus interest earned, into 4,455,844 shares of our common stock. These transactions converted in the aggregate $1,260,000 of our Debentures, leaving $140,000 remaining to be converted. As of June 30, 2008 and August 5, 2008, $140,000 of our Debentures remained outstanding and eligible for conversion.
Note 5 — Stockholders’ Deficit
In May 2007, the Company acquired SRS Energy through a reverse merger. Pursuant to the merger, the Company issued 38,624,784 shares of the Company’s common stock and a warrant exercisable until August 31, 2009 to purchase 1,923,495 shares of common stock at $.13 per share to the former stockholders of SRS Energy in exchange for the cancellation of all of the outstanding capital stock of SRS Energy and cancellation of an option to acquire 5% of the outstanding capital stock of SRS Energy. The Company affected a reverse split of its common stock at a ratio of 100 to 1 in January 2007. For accounting purposes, because the Company had been a public shell company prior to the merger, the merger was treated as an acquisition of the Company and a recapitalization of SRS Energy. As such, the historical information prior to the merger of the Company disclosed in the report is that of SRS Energy. Historical share amounts have been restated to reflect the effect of the merger.
In May 2007, the Company issued 9,366,800 shares of common stock ($.014 per share) upon the conversion of three promissory notes totaling $114,681 and accrued interest of $18,915.
In March 2008, the Company issued 4,433,067 shares of common stock ($0.15 per share) upon the conversion of an aggregate amount of $630,000 of the Company’s Debentures and accrued interest of approximately $35,000.
In April 2008, the Company issued 4,455,844 shares of common stock ($0.15 per share) upon the conversion of an aggregate amount of $630,000 of the Company’s Debentures and accrued interest of approximately $38,000.
Note 6 — Related Party Transactions
For the three and six months ended June 30, 2008, the Company incurred corporate and administrative fees of approximately $160 and $510, respectively, for expenses paid by its president on behalf of the Company. For the three and six months ended June 30, 2007, the Company incurred corporate and administrative fees of approximately $-0- and $4,000, respectively, for expenses paid by its president on behalf of the Company. The Company had been using the office of its president for corporate and administrative purposes until entering into a lease for office space which we occupied and began paying rent in January 2008.
The Company had a $72,103 advance from one of its board of director members at December 31, 2006 evidenced by a promissory note that accrued interest at 9.5% per annum. The promissory note also contained an option to acquire 5% of the outstanding capital stock of SRS Energy at a price of $250,000. In April 2007, the indebtedness under the promissory note was repaid and the promissory note was cancelled. Under its terms, the right to exercise the option to purchase shares survived after the repayment of the indebtedness under the note. As part of the merger consideration issued by the Company pursuant to the acquisition of SRS Energy, the Company issued a warrant exercisable until August 31, 2009 to purchase 1,923,495 shares of its common stock at $.13 per share to replace the option included in the promissory note on substantially similar terms as the option.
In August 2007, the Company entered into stock purchase agreements with certain members of the Board of Directors pursuant to which the members acquired shares of restricted stock. The directors issued notes to the Company in exchange for their stock purchases. See Note 7 for further discussion. These notes are recorded as notes receivable in Stockholders’ Deficit.

 

9


Table of Contents

The Company engages the law firm of Sauerwein, Simon and Blanchard (“SSB”) related to various issues including our reverse merger, our SB-2 registration statement, litigation matters and general business activity. A member of our board of directors is a partner of SSB. For the three and six months ended June 30, 2008, we incurred approximately $58,000 and $113,000, respectively, in legal fees with SSB. For the three and six months ended June 30, 2007, we incurred approximately $105,000 in legal fees with SSB. As of June 30, 2008, all amounts have been paid to SSB except for approximately $58,000.
The Company uses Arthur J. Gallagher (“AJG”) as its broker for business and property insurance. Our CEO’s brother is employed by AJG and is involved in the negotiation of coverage and premiums related to policies placed for the Company. For the three and six months ended June 30, 2008, the Company paid approximately $0 and $3,000, respectively, in commissions on policies placed by AJG. The Company placed no policies and paid no commissions in 2007.
Note 7 — Share-based Payments
The Company accounts for stock options and restricted stock issued to employees and directors under SFAS No. 123(R), in which share-based compensation cost to employees and directors is measured at the grant date, based on the estimated fair value of the award, and is recognized as expense over the requisite service period. The Company has no awards with market or performance conditions.
In March 2007, the Company adopted the 2007 Stock Option Plan (“Stock Plan”) for its employees, officers, directors and consultants, which includes an equity compensation plan for non-employee directors pursuant to which stock options and shares of restricted stock may be granted. The Company has reserved a maximum of 9,000,000 shares of common stock to be issued for the exercise of options or shares awarded under the Stock Plan. A proposal to increase the maximum share amount to 9,000,000 from 7,000,000 was approved by the Company’s stockholders at the Company’s Annual Stockholder Meeting, held on June 17, 2008.
In August 2007, the Company granted options under the Stock Plan to purchase an aggregate 3,850,000 shares of common stock to various employees that vest ratably over three years and options to purchase an aggregate 160,000 shares of common stock to directors that vest ratably over two years. All of these options have an exercise price of $0.15. The Company also issued an aggregate of 600,000 shares of restricted common stock to our directors. Under the agreements, each of our four directors agreed to purchase 150,000 shares of restricted common stock of the Company at a cost of $0.15 per share. The directors issued promissory notes to the Company in exchange for their stock purchases. The shares purchased by the directors under the agreements are restricted shares subject to a right, but not obligation, of repurchase by the Company. The Company may exercise its repurchase right only during the 60 day period following a director’s termination of service on the Board of Directors. Commencing on September 21, 2007, the Company’s repurchase rights lapse at the rate of 8,333 shares per month of continuous service by each director through September 21, 2008, when the Company’s repurchase rights lapse on 4,167 shares per month of continuous board service until the repurchase rights have lapsed on all restricted shares. At June 30, 2008, 266,680 shares remain subject to a right of repurchase. No outstanding options were cancelled, expired or exercisable as of June 30, 2008.
Additionally, upon commissioning of the pilot plant, an option to purchase 1,200,000 shares of common stock will be issued to our Chief Executive Officer. This option has not yet been granted, but if and when granted, will vest ratably over three years beginning on August 31, 2009.
The estimated fair value of stock option grants is computed using the binomial option-pricing model. Generally, expected volatility is based on historical periods commensurate with contractual term of options. However, since we have no history of stock price volatility as a public company at the time of the grants, we calculated volatility by considering historical volatilities of public companies in our industry. Due to the short history of our industry, the historical period used in our calculations is shorter than the contractual term of the options. The fair value for options granted was estimated as of June 30, 2008 to be $1.05 per share assuming a contract term of 6.1 years, a risk-free interest rate of 3.6%, expected volatility of 43.1% and no expected dividends. Stock option expense is recognized in the statements of operations ratably over the vesting period based on the number of options that are expected to ultimately vest. We currently use a forfeiture rate of zero percent for all existing share-based compensation awards since we have no historical forfeiture experience under our share-based payment plans. Our options have characteristics significantly different from those of traded options and changes in the assumptions can materially affect the fair value estimates.

 

10


Table of Contents

During the three and six months ended June 30, 2008, the Company recorded, as general and administrative expenses, stock based compensation of approximately $572,000 and $1,158,000 for stock options, respectively. No expense was recorded for the three and six months ended June 30, 2007 as the Company’s Stock Plan was adopted in March 2007 and grants were first made in August 2007. Related to these grants, the Company will record future compensation expense for stock options of approximately $760,000 for the remaining six months of 2008.
The potential tax benefit realizable for the anticipated tax deductions of the exercise of share-based payment arrangements totaled approximately $236,000 for the six months ended June 30, 2008. However, due to the uncertainty that the tax benefits will be realized, these potential benefits were not recognized currently.
As of June 30, 2008, there was approximately $3,021,000 of unrecognized compensation cost related to 4,010,000 nonvested stock options that we expect to ultimately vest. These options have a weighted average exercise price of $0.15. The unrecognized compensation cost is expected to be recognized over a weighted-average period of 2.96 years.
                 
            Weighted  
    Shares Under     Average  
    Option     Exercise Price  
Adoption of Stock Plan in March 2007
             
Granted
    4,010,000     $ 0.15  
Exercised
             
Forfeited
             
 
             
Options outstanding at December 31, 2007
    4,010,000       0.15  
Granted
             
Exercised
             
Forfeited
             
 
             
Options outstanding at June 30, 2008
    4,010,000          
 
             
 
               
Options exercisable at June 30, 2008
             
 
             
Pursuant to a settlement agreement, RAM Resources, L.L.C. obtained the right to acquire an aggregate of 1,923,495 shares of our common stock at a price of $0.13 per share. This warrant is exercisable during a two year term that started on August 29, 2007 and ends on August 29, 2009. RAM Resources, L.L.C. agreed to terminate the Letter Agreement and release all claims to acquire any shares of our stock. The fair value of $125,027 has been recorded in the Company’s general and administrative expenses for the year ended December 31, 2007 and additional paid in capital at December 31, 2007.
Note 8 — Commitments and Contingencies
Project management — The Company entered into an engagement agreement with Merrick & Company to develop a complete project management plan for the pilot development plan. For the three and six months ended June 30, 2008, we incurred approximately $17,000 and $74,000, respectively, for engineering, design and consulting services. After completing the project management plan, we engaged Merrick & Company to construct, test, and evaluate the HFTA equipment and the demonstration plant. As part of the testing and evaluation, Merrick & Company will provide construction observation of the demonstration unit in conjunction with Hazen Research, Inc. The system will demonstrate the efficacy of using biomass derived from municipal waste to produce ethanol using our licensed technologies and will allow us to develop the engineering data to design and construct a small commercial plant. Our engagement calls for further payments to Merrick & Company on an as billed basis as they proceed with the engineering review and testing of our technology.

 

11


Table of Contents

In December 2007, the Company entered into an agreement with Hazen Research, Inc. (“Hazen”) to install and operate the HFTA equipment at Hazen’s facility in Golden, Colorado. The agreement also contemplates the expansion of the scope of work to include the construction and operation of the demonstration plant. We are billed at an hourly rate for time used by Hazen employees in connection with our projects. For the three and six months ended June 30, 2008, we incurred approximately $25,000 and $115,000, respectively, for the proof of concept phase with Hazen. We are currently working with Hazen to develop an estimate of the costs to construct and operate the demonstration unit at their facility.
Leases — We entered into a lease on October 16, 2007 (and took occupancy in January 2008) to rent approximately 1,800 square feet of office space for use as our corporate office, located at 7386 Pershing Ave. in St. Louis, Missouri for a term of three years. Our monthly rent under the lease is $1,800 plus the cost of utilities. We entered into a lease for office furniture in January 2008. The lease payments are approximately $420 plus applicable taxes per month for 36 months. This lease is accounted for as a capital lease for accounting purposes.
Note 9 — Subsequent Events
Regulation S Offering
On July 3, 2008, the Company entered into a letter agreement (the “Agreement”) with Concord Business Development (“Concord”) to commence an offering of our common stock pursuant to and in reliance upon the exemption from securities registration afforded by the provisions of Regulation S as promulgated by the Securities and Exchange Commission under the Securities Act of 1933, as amended, in which we seek to raise up to $5.0 million (the “Offering”). Under the agreement, the Company will be paid an amount equal to 60% of the total offering proceeds. As of August 13, 2008, the Company is working with Concord on the necessary documents for closing on the first round of funding. We cannot be assured of closing on the Offering in part or in its entirety. Without this funding on a timely basis, the development of our technologies, facilities and products will be delayed and we could be forced to limit or terminate our operations altogether.
Simultaneous with our entry into the Agreement, we agreed to issue warrants to purchase shares of our common stock at a price of $1.25 per share to Carlton Phips, Ltd. (“Carlton”) in an amount equal to 24% of the total shares issued in the Offering as compensation to Carlton for introducing the Company to Concord. These warrants may be exercised at any time within five years after the date of issuance.
There is no assurance that the Company will raise a portion of or the full $5.0 million under the Offering. Please see the Risk Factor relating to this issue under Part II, Item 1A for further information.
Acquisition of Biomass North America Licensing, Inc.
On July 15, 2008, we entered into an Agreement and Plan of Merger with Biomass North America Licensing, Inc. (“Biomass”) whereby Biomass will be merged with and into a wholly-owned subsidiary of CleanTech Biofuels, Inc. The merger agreement is subject to certain conditions to closing, including approval of the Boards of Directors of both companies. Biomass holds an exclusive license to use patent pending technology to clean and separate municipal solid waste.
Pursuant to the terms of this agreement, we will be required to issue 2,000,000 shares of our common stock to the shareholders of Biomass at closing and deposit an additional 4,000,000 shares of our common stock into an escrow account. The 4,000,000 shares of our common stock held in escrow will be released upon commencement of a commercial project that utilizes the technology owned by Biomass.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Statement Regarding Forward-Looking Information
From time to time, we make written or oral statements that are “forward-looking,” including statements contained in this report and other filings with the Securities and Exchange Commission (“SEC”) and in our reports to stockholders. The Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended, provide a safe harbor for such forward-looking statements. All statements, other than statements of historical facts, included herein regarding our strategy, future operations, financial position, future revenues, projected costs, prospects, plans, objectives and other future events and circumstances are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “would,” “should” and similar expressions or negative expressions of these terms. Such statements are only predictions and, accordingly, are subject to substantial risks, uncertainties and assumptions.

 

12


Table of Contents

Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. We caution you that any forward-looking statement reflects only our belief at the time the statement is made. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we cannot guarantee our future results, levels of activity, performance or achievements. Refer to our Risk Factors section of our annual report on Form 10-KSB for the year ended December 31, 2007, filed with the Securities and Exchange Commission on March 28, 2008, for a full description of factors we believe could cause actual results or events to differ materially from the forward-looking statements that we make. These factors include:
   
the commercial viability of our technologies,
 
   
our ability to maintain and enforce our exclusive rights to our technologies,
 
   
our ability to raise additional capital on favorable terms to continue developing our technologies,
 
   
our disputes and resulting litigation with the licensor of our PSC technology,
 
   
the demand for and production costs of ethanol,
 
   
competition from other alternative energy technologies, and
 
   
other risks and uncertainties detailed from time to time in our filings with the SEC.
Although we believe the expectations reflected in our forward-looking statements are based upon reasonable assumptions, it is not possible to foresee or identify all factors that could have a material and negative impact on our future performance. The forward-looking statements in this report are made on the basis of management’s assumptions and analyses, as of the time the statements are made, in light of their experience and perception of historical conditions, expected future developments and other factors believed to be appropriate under the circumstances.
Company Overview
We are a development stage company that intends to:
   
complete the research and development of our licensed technologies, which we believe when combined can convert municipal solid waste into ethanol; and
 
   
explore, develop and/or license additional technologies for processing waste into energy products as opportunities to do so present themselves.
Our licensed technologies are:
   
the Pressurized Steam Classification technology, which we refer to as our “PSC” technology, invented at the University of Huntsville, Alabama, that uses a pressurized steam classification vessel to convert municipal solid waste, also known as MSW, into cellulosic material while simultaneously segregating and eliminating any inorganic materials in the solid waste and cleaning recyclable materials in the MSW;
 
   
the sulfuric acid hydrolysis process, which we refer to as our “Brelsford” technology, developed by Brelsford Engineering, Inc., that employs an acid hydrolysis process to convert cellulosic material into fermentable sugars, which can then be fermented into ethanol; and
 
   
the nitric acid hydrolysis process, which we refer to as our “HFTA” technology, developed by scientists working at the University of California, Berkeley, that incorporates anticipated improvements in chemical reaction by which acid hydrolysis occurs.
We were originally incorporated in 1996 as Long Road Entertainment, Inc., and were formed to operate as a holding company for businesses in the theater, motion picture and entertainment industries. We ceased conducting that business in 2005 and were dormant until the fall of 2006, at which time our founder and then controlling stockholder decided to pursue the sale of the company. In anticipation of that sale, we changed our name to Alternative Ethanol Technologies, Inc.

 

13


Table of Contents

On March 27, 2007, we entered into an Agreement and Plan of Merger and Reorganization in which we agreed to acquire SRS Energy, Inc., a Delaware corporation (“SRS Energy”), which is the holder of the technology licenses. Pursuant to the merger agreement, SRS Acquisition Sub Inc. our wholly-owned subsidiary, merged into SRS Energy with SRS Energy as the surviving corporation. We consummated the merger on May 31, 2007 resulting in SRS Energy becoming our wholly-owned subsidiary. Today, SRS Energy is our principal operating company. Effective August 2, 2007, we changed our name to CleanTech Biofuels, Inc.
SRS Energy was originally formed, in July 2004, as a wholly-owned subsidiary of Supercritical Recovery Systems, Inc., a Delaware corporation. At that time, Supercritical Recovery Systems was a licensee of various technologies for the processing of waste materials into usable products. While investigating different technologies, Supercritical Recovery Systems, Inc. was introduced to the PSC and Brelsford technologies and secured licenses to the technologies in SRS Energy. Prior to our acquisition of SRS Energy, Supercritical Recovery Systems, Inc. distributed approximately 80% of its ownership of SRS Energy to the stockholders of Supercritical Recovery Systems, Inc. Since our acquisition of SRS Energy, Supercritical Recovery Systems, Inc. has ceased its business activities with respect to licensing other technologies.
Plan of Operation
The following discussion of our plan of operation should be read in conjunction with the financial statements and related notes to the financial statements included elsewhere in this report. This discussion contains forward-looking statements that relate to future events or our future financial performance. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance. These risks and other factors include, among others, those listed under “Statement Regarding Forward-Looking Information.”
The license to the PSC technology grants SRS Energy limited exclusive rights to use the technology to process municipal solid waste and convert the cellulosic component of that waste to a homogenous feedstock to produce ethanol in the United States, subject to the right of Bio-Products to request five sites to construct solid waste to ethanol plants in the United States. SRS Energy’s license to the Brelsford technology is limited to the production of fuel grade ethanol in the United States. The license is exclusive with regard to the conversion of MSW to cellulosic biomass and non-exclusive with respect to the conversion of other feedstock for the production of ethanol. The license to the HFTA technology provides us an exclusive worldwide license to use the technology for the production of energy products from MSW and a non-exclusive license to use the technology to produce energy products from other feedstocks. By coupling these technologies, we believe we may have the ability to extract biomass from curbside solid waste (among other potential sources of cellulosic material) and convert it into fuel grade ethanol.
We have no operating history as a producer of ethanol and have not constructed any ethanol plants to date. We have not earned any revenues to date and expect that our current capital and other existing resources will be sufficient only to complete a portion of the testing of our technologies and to provide a limited amount of working capital. We will require substantial additional capital to implement our business plan and we may be unable to obtain the capital required to build any commercial plants. Our strategy is to build our company in several phases with the ultimate goal of becoming a leading producer of ethanol and other combustible fuels from municipal waste and other feedstocks.

 

14


Table of Contents

We are currently focusing on testing, demonstrating and commercializing our existing licensed technologies. On an ongoing basis, we intend to continue investigating opportunities to develop or acquire complementary technologies, especially those that would allow us to improve our existing processes or to add value to the various byproducts produced by those processes. In addition, we will look for opportunities to combine our technologies with other synergistic processes in innovative energy parks, where some of our byproducts, such as lignin, could be used as inputs to other processes, such as gasifiers, that could produce inputs for us, such as steam. We have structured our Strategic Plan on the following three phases with respect to the development and commercialization of our existing technologies:
Proof of Concept/Demonstration Phase
In our current stage of our development, we are seeking to prove that biomass derived using the PSC technology does not include any contaminants or residue that prohibit the chemical or biologic reactions necessary to complete the sacchrification and fermentation processes required to produce fuel grade ethanol. We believe that the HFTA technology may prove useful as a pretreatment for a variety of other hydrolysis technologies being developed to separate hemicelluloses and then using commercially available enzymes to separate the remaining cellulose and lignin. In order to determine whether this is true, we also are testing the HFTA equipment as a first-stage to separate hemicellulose and then using commercially available enzymes to separate the cellulose. In addition to using the HFTA technology for hydrolyzing biomass, we are using the HFTA equipment to test a variety of other feedstocks, including corn stover, switch grass and wood waste using these same methods of hydrolyzing biomass. We believe the hydrolsate derived from these various processes and feedstocks can be fermented into alcohol.
Concurrent with the proof of concept, we are completing the design and engineering of a demonstration unit that would incorporate all of our technologies for sacchrification and fermentation into a continuously operating unit. We project that this unit will process approximately four tons of MSW, or about one ton of dry biomass per operating day, which on average is eight hours. The purpose of the unit is to demonstrate the complete system for converting biomass derived from MSW into ethanol. Final details of the demonstration plant design will depend on results of the proof of concept phase; however, we have substantially completed these designs and believe we will be able to move to fabrication, procurement and construction of the demonstration unit upon completing the proof of concept testing provided we are able to obtain the financing necessary to do so. After completing construction of the demonstration unit, we intend to operate the unit for a period of time, currently anticipated to be two to three months, in order to conduct testing and evaluation necessary to complete the design of a small commercial plant. While we have not yet completed the project management plan for the demonstration phase of the project, we anticipate the demonstration phase of the project will require nine to twelve months following the end of the testing phase to complete.
Commercialization Phase
Before we attempt to implement our technology on a larger scale, we anticipate building and operating a small commercial plant that will process a minimum of 100 tons of MSW per operating day. The final size of this small scale commercial plant will be determined based on a number of factors that we are currently evaluating. The purpose of building a small scale commercial plant is to demonstrate at a small commercial level the workings of the integrated system, including the PSC technology, in order to have sufficient information with respect to materials handling and operation of the technology to enable us to utilize more traditional project financing for the implementation of the technology on a larger scale.
Replication and Rollout Phase
We intend to follow a systematic evaluation process in identifying and selecting additional sites for the construction of full-scale operating plants in order to focus on those with the best near-term and long-term potential. If market conditions are not favorable for the construction of new plants, we may consider licensing our technology to third parties with existing waste-to-energy facilities. To date, we have not identified any sites for a full-scale facility or commenced any material discussions with any party regarding building a full-scale operating plant and/or licensing our technology to a third-party. We have only preliminarily begun to explore these possibilities.
Our ability to implement this strategy will depend on our ability to raise significant amounts of additional capital and to hire appropriate managers and staff. Our success will also depend on a variety of market forces and other developments beyond our control.

 

15


Table of Contents

Results of Operations
The following table sets forth the amounts of expenses and changes represented by certain items reflected in our consolidated statements of operations for the three and six months ended June 30, 2008 and 2007:
                                 
    Three months ended  
    June 30, 2008     June 30, 2007     $ Change     % Change  
Costs and expenses:
                               
General and administrative
  $ 675,819     $ 229,344     $ 446,475       194.7 %
Professional fees
    78,946       154,873       (75,927 )     -49.0 %
Research and development
    53,812             53,812       N/M  
 
                         
 
    808,577       384,217       424,360          
 
                               
Other expense (income):
                               
Interest
    4,136       17,500       (13,364 )     -76.4 %
Amortization of technology license
    3,750             3,750       N/M  
Interest income
    (252 )     (5,020 )     4,768       -95.0 %
 
                         
 
                               
Net loss applicable to common stockholders
  $ 816,211     $ 396,697     $ 419,514          
 
                         
                                 
    Six months ended  
    June 30, 2008     June 30, 2007     $ Change     % Change  
Costs and expenses:
                               
General and administrative
  $ 1,325,281     $ 233,351     $ 1,091,930       467.9 %
Professional fees
    190,892       156,843       34,049       21.7 %
Research and development
    236,916             236,916       N/M  
 
                         
 
    1,753,089       390,194       1,362,895          
 
                               
Other expense (income):
                               
Interest
    23,887       21,097       2,790       13.2 %
Amortization of technology license
    7,500             7,500       N/M  
Interest income
    (5,979 )     (5,020 )     (959 )     19.1 %
 
                         
 
                               
Net loss applicable to common stockholders
  $ 1,778,497     $ 406,271     $ 1,372,226          
 
                         
General
Prior to April 2007, we had limited operations. In April 2007, we raised $1,400,000 and commenced implementing our plan of operation. As a result, our increased operating activities and the issuance of options under the 2007 Stock Option Plan (and the resulting expense in accordance with FAS 123R) are the primary reasons we experienced significant increases in our costs and expenses when comparing the three and six months ended June 30, 2008 with the three and six months ended June 30, 2007. In particular, we experienced the following specific changes in our operations:
Three months ended June 30, 2008 compared to the three months ended June 30, 2007
Costs and expenses:
General and administrative — The increase in 2008 is due primarily to recording approximately $572,000 in share-based compensation expense (FAS 123R) and expenses for our office lease and related expenses which commenced in January 2008.
Professional fees — The decrease in 2008 is due to costs in 2007 incurred for legal, consulting and accounting fees primarily related to our reverse merger and related Securities and Exchange Commission registration filing.
Research and development — The increase in 2008 is due to payments made to Merrick & Company and Hazen Research, Inc. as we continued to progress through our proof of concept/demonstration phase which began during the third quarter of 2007. Both parties are involved in the testing, evaluation, design and construction of our proof of concept / demonstration phase and commercialization phase of our technologies.

 

16


Table of Contents

Other expense (income):
Interest expense — The decrease in 2008 is due primarily to the conversion of $1.26 million of our $1.4 million Series A Convertible Debentures, which were originally issued in April 2007. Subsequent to these conversions during the second quarter of 2008, interest no longer accrues on the debentures which were converted. Interest continues to accrue at 6.0% per annum on the remaining $140,000 of debentures outstanding. Interest on the debentures for the three months ended June 30, 2008 and 2007 is $3,750 and $17,500, respectively.
Amortization of technology license — As the proof of concept/demonstration phase began during the third quarter 2007 we have begun to amortize the technology license fees previously capitalized.
Interest income — The income in 2007 is primarily interest on $450,000 of promissory notes issued to us as part of the consideration for the issuance of the Series A Convertible Debentures. We received the $450,000 plus accrued interest on March 14, 2008 and thus no longer earn interest at 6% per annum on those notes.
Six months ended June 30, 2008 compared to the six months ended June 30, 2007
Costs and expenses:
General and administrative — The increase in 2008 is due primarily to recording approximately $1.16 million in share-based compensation expense (FAS 123R), salary paid to our Chief Executive Officer and expenses for our office lease and related expenses which commenced in January 2008.
Professional fees — The increase in 2008 is due to increased costs incurred for legal, consulting and accounting fees related to various filings with the Securities and Exchange Commission (as we became a reporting company in January 2008), litigation matters and an increase in general business activities.
Research and development — The increase in 2008 is due to payments made to Merrick & Company, Hazen Research, Inc. and HFTA as we continue to progress through our proof of concept/demonstration phase which began during the third quarter of 2007.
Other expense (income):
Amortization of technology license — As the proof of concept/demonstration phase began during the third quarter 2007 we have begun to amortize the technology license fees previously capitalized.
Liquidity and Capital Resources
As a development-stage company, we have no revenues and will be required to raise additional capital in order to execute our business plan and commercialize our products.
On July 3, 2008, the Company entered into a letter agreement (the “Agreement”) with Concord Business Development (“Concord”) to commence an offering of our common stock pursuant to and in reliance upon the exemption from securities registration afforded by the provisions of Regulation S as promulgated by the Securities and Exchange Commission under the Securities Act of 1933, as amended, in which we seek to raise up to $5.0 million (the “Offering”). Under the agreement, the Company will be paid an amount equal to 60% of the total offering proceeds. As of August 13, 2008, the Company is working with Concord on the necessary documents for closing on the first round of funding. We cannot be assured of closing on the Offering in part or in its entirety. Without this funding on a timely basis, the development of our technologies, facilities and products will be delayed and we could be forced to limit or terminate our operations altogether.
Simultaneous with our entry into the Agreement, we agreed to issue warrants to purchase shares of our common stock at a price of $1.25 per share to Carlton Phips, Ltd. (“Carlton”) in an amount equal to 24% of the total shares issued in the Offering as compensation to Carlton for introducing the Company to Concord. These warrants may be exercised at any time within five years after the date of issuance.
There is no assurance that the Company will raise a portion of or the full $5.0 million under the Offering. Please see the Risk Factor relating to this issue under Part II, Item 1A for further information.

 

17


Table of Contents

We expect cash raised through our agreement with Concord will be sufficient to fund approximately the next six months of our plan of operation. Thereafter, we anticipate requiring additional capital to complete the demonstration and commercialization phases of our plan of operation. These costs will be substantially greater than our current available funds. We currently expect attempting to obtain additional financing through the sale of additional equity and/or possibly through strategic alliances with larger energy or waste management companies. However, we may not be successful in securing additional capital. If we are not able to obtain additional financing in the near-term future, we will be required to delay our development until such financing becomes available. We anticipate that the current dispute with Bio-Products will make it significantly more difficult for us to raise capital. Further, even assuming that we secure additional funds, we may never achieve profitability or positive cash flow. If we are not able to timely and successfully raise additional capital and/or achieve profitability or positive cash flow, we will not have sufficient capital resources to implement our business plan.
Off-Balance Sheet Arrangements
There are no off-balance sheet arrangements.
Critical Accounting Policies
We prepare our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America. Certain accounting issues require management estimates and judgments for the preparation of financial statements. Our management periodically evaluates the estimates and judgments made. Management bases its estimates and judgments on historical experience and on various factors that are believed to be reasonable under the circumstances. Actual results may differ from these estimates as a result of different assumptions or conditions.
We believe that the estimates, assumptions and judgments relating to research and development costs, share-based compensation and income tax matters have the greatest potential impact on our financial statements. Therefore, we consider these to be our critical accounting estimates. Our critical accounting policies and estimates are more fully described in our annual report on Form 10-KSB for the year ended December 31, 2007, filed with the Securities and Exchange Commission on March 28, 2008. Our critical accounting policies and estimate assumptions have not changed during 2008.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
None.
Item 4T. Controls and Procedures
Effectiveness of Disclosure Controls and Procedures — We maintain a set of disclosure controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended (the “Act”), is recorded, processed, summarized and reported within the time periods specified by the Security and Exchange Commission’s (the “SEC”) rules and regulations. Disclosure controls are also designed with the objective of ensuring that this information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Our management does not expect that our disclosure controls and procedures will necessarily prevent all fraud and material error. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving the objectives outlined above. Based on their most recent evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures are effective at that reasonable assurance level at June 30, 2008. Further, the design of a control system must reflect the fact that there are resource constraints, including, but not limited to having three total employees (chief executive officer, general counsel and chief financial officer), and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple error or mistake.
Changes in Internal Control Over Financial Reporting — During the three months ended June 30, 2008, there were no material changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

18


Table of Contents

PART II. OTHER INFORMATION
Item 1. Legal Proceedings
CleanTech Biofuels, Inc. v. Bioproducts International, Inc . On January 9, 2008, CleanTech Biofuels, Inc. and our wholly-owned subsidiary, SRS Energy, Inc. (“SRS Energy”), filed suit in Missouri Circuit Court seeking damages against Bio-Products International, Inc. (“Bio-Products”), the licensor of our PSC technology, Clean Earth Solutions, Inc., which we believe to be an affiliate of Bio-Products (“CES”), and various shareholders and officers of those companies for, among other things, fraudulent acts, civil conspiracies, and tortuous interference with our business. We also are seeking to rescind a sublicense with respect to the use of the PSC technology in five sites that we granted back to Bio-Products. The case was subsequently moved to the Federal District Court in St. Louis, Missouri and the claims against individuals associated with CES were dismissed and the remaining claims were consolidated with our ongoing arbitration.
In addition, we have filed a demand for arbitration seeking, among other things, a declaration that we are in full compliance with the terms of the License Agreement between SRS Energy and Bio-Products dated August 17, 2005 (the “License Agreement”). We filed the arbitration demand in response to what we believe was a baseless attempt by Bio-Products to terminate the License Agreement in violation of the terms of the License Agreement and are seeking damages against Bio-Products for its fraudulent attempt to terminate the License Agreement. The American Arbitration Association has determined that the arbitration will occur in St. Louis. In early April, an arbitrator was selected to hear this matter. We anticipate that the arbitration will occur in October 2008, at the earliest. On May 8, 2008, we filed a Temporary Restraining Order in the Arbitration seeking to require Bio-Products to provide us with biomass for testing purposes as required in the License Agreement. On July 3, 2008, we entered into a consent judgment pursuant to which Bio-Products agreed to provide us with biomass for testing purposes.
If we are not successful in our arbitration and lawsuit, that failure could have a materially adverse effect on our business. See the Risk Factors and previous disclosure of this legal proceeding in our Annual Report on Form 10-KSB for the year ended December 31, 2007, filed with the Securities and Exchange Commission (“SEC”) on March 28, 2008, our Form 10-Q for the three months ended March 31, 2008 filed with the SEC on May 15, 2008 and our Form 8-K filed with the SEC on January 10, 2008, all of which are incorporated herein by reference.
Item 1A. Risk Factors
We may not be able to raise the full $5.0 million with Concord Business Development (“Concord”)
The Company entered into a letter agreement with Concord to commence an offering of our common stock pursuant to Regulation S, in which we seek to raise up to $5.0 million. The company receives 60% of these proceeds. The Company is currently working with Concord on the necessary documents for closing on the first round of funding. If we are unable to complete a portion of or the full funding, we will be required to obtain additional funding sooner than expected. As disclosed previously in this report and in our risk factors in our Form 10-KSB for the year ended December 31, 2007, we will require significant capital in order to complete our proof of concept, commercialization and replication/rollout phases. In addition to the funding raised with Concord, we will require additional funding to complete these phases. Without the full funding with Concord, we will need to raise additional capital sooner than expected and may not be able to complete this funding. Without this additional funding on a timely basis, the development of our technologies, facilities and products could be delayed and we could be forced to limit or terminate our operations altogether.
In addition to the risk factor above and the other information set forth in this report, you should carefully consider the risk factors discussed in Part II, Item 6 in our Annual Report on Form 10-KSB for the year ended December 31, 2007, which could materially affect our business, financial condition or future results. These cautionary statements are to be used as a reference in connection with any forward-looking statements. The factors, risks and uncertainties identified in these cautionary statements are in addition to those contained in any other cautionary statements, written or oral, which may be made or otherwise addressed in connection with a forward-looking statement or contained in any of our subsequent filings with the Securities and Exchange Commission.

 

19


Table of Contents

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds — None.
Item 3. Defaults Upon Senior Securities — None.
Item 4. Submission of Matters to a Vote of Security Holders —
The Company’s annual meeting of stockholders was held on June 17, 2008. At the meeting, the stockholders voted on matters as follows:
1. Election of Board of Directors (Class 1) —
                         
    Votes For     Votes Against     Votes Withheld  
Paul Simon, Jr.
    36,837,021             4,479,203  
Benton Becker
    41,316,224              
Edward P. Hennessey, Larry McGee and Ira Langenthal continue to serve as members of our Board of Directors.
2. Increase reserve for 2007 Option Plan from 7,000,000 shares to 9,000,000 shares —
         
Votes For
    29,761,555  
Votes Against
    5,422,766  
Votes Abstained
    134,333  
3. Ratification of Auditor —
         
Votes For
    41,260,947  
Votes Against
     
Votes Abstained
    55,275  
Item 5. Other Information — None.
Item 6. Exhibits
(a) The following documents are filed as a part of this Report.
         
EXHIBIT NO.   DESCRIPTION
       
 
  2.1    
Agreement and Plan of Merger and Reorganization by and among Cleantech Biofuels, Inc., Biomass NA Acquisition Subsidiary, Inc. and Biomass North America Licensing, Inc. dated as of July 14, 2008
  31.1    
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
  31.2    
Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
  32.1    
Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002) of Chief Executive Officer.
  32.2    
Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002) of Principal Financial Officer.

 

20


Table of Contents

SIGNATURES
In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
 
  CLEANTECH BIOFUELS, INC.    
 
       
Date: August 13, 2008
  /s/ Edward P. Hennessey, Jr.
 
Edward P. Hennessey, Jr.
   
 
  Chief Executive Officer    
 
       
Date: August 13, 2008
  /s/ Thomas Jennewein
 
Thomas Jennewein
   
 
  Chief Financial Officer and    
 
  Principal Accounting Officer    

 

21


Table of Contents

INDEX TO EXHIBITS
         
EXHIBIT NO.   DESCRIPTION
       
 
  2.1    
Agreement and Plan of Merger and Reorganization by and among Cleantech Biofuels, Inc., Biomass NA Acquisition Subsidiary, Inc. and Biomass North America Licensing, Inc. dated as of July 14, 2008
  31.1    
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
  31.2    
Certification of Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Securities Exchange Act, as amended.
  32.1    
Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002) of Chief Executive Officer.
  32.2    
Certification (Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002) of Principal Financial Officer.

 

22

Exhibit 2.1
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION
AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”), dated as of July 14, 2008, by and among CleanTech Biofuels, Inc., a Delaware corporation (the “Parent”), Biomass NA Acquisition Subsidiary, Inc., a Delaware corporation (the “Acquisition Subsidiary”) and Biomass North America Licensing, Inc., an Illinois corporation (the “Company”). The Parent, the Acquisition Subsidiary and the Company are each a “Party” and referred to collectively herein as the “Parties.”
NOW THEREFORE, in consideration of the mutual promises and covenants herein set forth and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows:
ARTICLE I
THE MERGER
1.1 The Merger . Upon and subject to the terms and conditions of this Agreement, the Acquisition Subsidiary shall merge with and into the Company at the Effective Time (as defined below). From and after the Effective Time, the separate corporate existence of the Acquisition Subsidiary shall cease and the Company shall continue as the surviving corporation in the Merger (the “Surviving Corporation”). The “Effective Time” shall be the later to occur of the time at which a certificate of merger (the “Certificate of Merger”) and other appropriate or required documents prepared and executed in accordance with the DGCL are filed with the Secretary of State of Delaware. The Merger shall have the effects set forth in Section 259 of the DGCL.
1.2 The Closing . The closing of the transactions contemplated by this Agreement (the “Closing”) shall take place at the offices of Collins & Collins, P.C. in Chicago, Illinois commencing at 10:00 a.m. local time on July 17, 2008, or, if all of the conditions to the obligations of the Parties to consummate the transactions contemplated hereby have not been satisfied or waived by such date, on such mutually agreeable later date as soon as practicable (and in any event not later than three (3) business days) after the satisfaction or waiver of all conditions (the “Closing Date”).
1.3 Actions at the Closing . At the Closing:
(a) the Company shall deliver to the Parent and the Acquisition Subsidiary the various certificates, instruments and documents referred to in Section 5.2;
(b) the Parent and the Acquisition Subsidiary shall deliver to the Company the various certificates, instruments and documents referred to in Section 5.3;
(c) the Surviving Corporation shall file with the Secretary of State of the State of Delaware the Certificate of Merger;
(d) each of the stockholders of record of the Company immediately prior to the Effective Time (collectively, the “Company Stockholders”) shall deliver to the Parent the certificate(s) representing his, her or its Company Shares (as defined below) (except for shares then or thereafter qualifying as Dissenting Shares);
(e) the Parent shall deliver to its transfer agent irrevocable instructions to issue and deliver the shares of Parent Common Stock in accordance with the provisions of Section 1.7 of this Agreement together with such legal opinions or other documentation as the Parent’s transfer agent may require in order to effect the issuances contemplated hereby;
(f) the current officers and directors of the Parent shall deliver their written resignations as such;
(g) the Parent shall take such action and cause to take effect such amendments of its bylaws and such resolutions of its Board of Directors as may be necessary or appropriate to elect the designees of the Company as officers and members of the Board of Directors of the Parent;

 

 


 

1.4 Additional Actions . If at any time after the Effective Time the Surviving Corporation shall consider or be advised that any deeds, bills of sale, assignments or assurances or any other acts or things are necessary, desirable or proper (a) to vest, perfect or confirm, of record or otherwise, in the Surviving Corporation, its right, title or interest in, to or under any of the rights, privileges, powers, franchises, properties or assets of either the Company or Acquisition Subsidiary or (b) otherwise to carry out the purposes of this Agreement, the Surviving Corporation and its proper officers and directors or their designees shall be authorized (to the fullest extent allowed under applicable law) to execute and deliver, in the name and on behalf of either the Company or Acquisition Subsidiary, all such deeds, bills of sale, assignments and assurances and do, in the name and on behalf of the Company or Acquisition Subsidiary, all such other acts and things necessary, desirable or proper to vest, perfect or confirm its right, title or interest in, to or under any of the rights, privileges, powers, franchises, properties or assets of the Company or Acquisition Subsidiary, as applicable, and otherwise to carry out the purposes of this Agreement.
1.5 Certificate of Incorporation and Bylaws .
(a) The certificate of incorporation of the Company in effect immediately prior to the Effective Time shall be the certificate of incorporation of the Surviving Corporation until duly amended or repealed.
(b) The bylaws of the Company in effect immediately prior to the Effective Time shall be the bylaws of the Surviving Corporation until duly amended or repealed.
1.6 Directors and Officers . The directors and officers of the Acquisition Subsidiary immediately prior to the Merger shall be the initial directors and officers of the Surviving Corporation and shall hold office from the Effective Time until their respective successors are duly elected or appointed and qualify, or such persons are otherwise removed, in accordance with the certificate of incorporation and bylaws of the Surviving Corporation, or as otherwise provided by law.
1.7 Conversion of Securities .
(a) At the Effective Time, all of the shares of common stock of Company (the “Company Common Stock”), issued and outstanding immediately prior to the Effective Time, shall, by virtue of the Merger and without any action on the part of the holders thereof, automatically be converted into the right to receive a total of 6,000,000 fully paid and non-assessable share of common stock, par value $0.001 per share, of Parent (the “Parent Common Stock”). Of such shares 2,000,000 shares shall be to the shareholders pro rata based on ownership of Company Common Stock and 4,000,000 shares shall be deposited into escrow to be paid to the shareholders of the Company upon commencement of a Commercial Development as set forth in the License and Joint Development Agreement between the Company, Biomass North America, L.L.C. and Anthony P. Noll pursuant to an escrow agreement satisfactory to all parties attached hereto as Exhibit 1.7 (the “License Agreement”).
(b) At the Effective Time, all outstanding shares of Company Common Stock shall be cancelled and retired and each certificate or other instrument theretofore evidencing the right to receive Company Common Stock shall thereafter represent only the right to receive the number of shares of Parent Common Stock into which such shares of Company Common Stock shall have been converted pursuant to Section 1.7(a) above upon surrender of such certificate to Parent. The record holder of each such outstanding certificate representing shares of Company Common Stock shall, after the Effective Time, be entitled to vote the shares of Parent Common Stock into which such shares of Company Common Stock shall have been converted on any matters on which holders of record of the Parent Common Stock, as of any date subsequent to the Effective Time, shall be entitled to vote. In any matters relating to such certificates of Company Common Stock, Parent may rely conclusively upon the record of shareholders maintained by Company containing the names and addresses of the holders of record of Company Common Stock on the Effective Date.

 

2


 

(c) The shares of Parent Common Stock that are being issued in connection with the Merger as well as any securities issued by Parent in accordance with Section 1.7(b), and any shares of Parent Common Stock issuable upon exercise thereof, (collectively, the “Parent Securities”) are being issued pursuant to an exemption from registration provided for in Section 4(2) of the Securities Act and the rules and regulations promulgated thereunder. Any Parent Securities issued in the Merger will not be transferable except (i) pursuant to an effective registration statement under the Securities Act or (ii) upon receipt by Parent of a written opinion of counsel reasonably satisfactory, in form and substance, to Parent to the effect that the proposed transfer is exempt from the registration requirements of the Act and applicable state securities laws. Each certificate representing any Parent Securities shall be subject to stop transfer instructions and shall bear the following legend or a legend of similar import:
NO TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY BE MADE EXCEPT (A) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND THE RULES AND REGULATIONS IN EFFECT THEREUNDER AND ALL APPLICABLE STATE SECURITIES OR “BLUE SKY” LAWS (SUCH FEDERAL AND STATE LAWS, THE “SECURITIES LAWS”) OR (B) IF THE COMPANY HAS BEEN FURNISHED WITH AN OPINION OF COUNSEL FOR THE HOLDER, WHICH OPINION AND COUNSEL SHALL BE REASONABLY SATISFACTORY TO THE COMPANY TO THE EFFECT THAT SUCH TRANSFER, SALE, ASSIGNMENT, PLEDGE, HYPOTHECATION OR OTHER DISPOSITION IS EXEMPT FROM THE REGISTRATION OR SIMILAR REQUIREMENTS OF THE SECURITIES LAWS.
(d) At the Effective Time, each share of common stock of Acquisition Subsidiary that is outstanding immediately prior to the Effective Time, shall, without further action, automatically be converted into one (1) fully paid and non-assessable share of common stock of the Surviving Corporation.
1.8 Stock Certificates . At or following the Effective Time, each holder of an outstanding certificate or certificates representing Company Common Stock shall surrender the same to Parent or its transfer agent and Parent shall, in exchange therefor, cause to be issued to the holder of such certificate(s) a new certificate representing the number of shares of Parent Common Stock into which shares of Company Common Stock theretofore represented by the Certificates so surrendered shall have been converted as provided in Section 1.7(a) hereof, and the surrendered certificate(s) shall be cancelled. Until so surrendered and exchanged, each such certificate shall represent solely the right to receive the number of shares of Parent Common Stock pursuant to Section 1.7(a) above or, if the holder holds Dissenting Shares, to demand payment of the fair market value thereof pursuant to the DGCL or to exercise any other rights under the DGCL.
1.9 No Further Rights . From and after the Effective Time, no Company Shares shall be deemed to be outstanding, and holders of Certificates shall cease to have any rights with respect thereto, except as provided herein or by law.
1.10 Closing of Transfer Books . At the Effective Time, the stock transfer books of the Company shall be closed and no transfer of Company Shares shall thereafter be made. If, after the Effective Time, Certificates are presented to the Parent or the Surviving Corporation, they shall be cancelled and exchanged for shares of Parent Common Stock in accordance with Section 1.7.
ARTICLE II
REPRESENTATIONS AND WARRANTIES OF THE COMPANY
Except as set forth in the disclosure schedule provided by the Company to the Parent (the “Disclosure Schedule”), the Company represents and warrants to the Parent as follows:
2.1 Organization, Qualification and Corporate Power . The Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware. The Company is duly qualified to conduct business and is in good standing under the laws of each jurisdiction in which the nature of its businesses or the ownership or leasing of its properties requires such qualification, except where the failure to be so qualified or in good standing, individually or in the aggregate, has not had and would not reasonably be expected to have a Company Material Adverse Effect (as defined below). The Company has all requisite corporate power and authority to carry on the businesses in which it is engaged and to own and use the properties owned and used by it. The Company has furnished or made available to the Parent complete and accurate copies of its articles of incorporation and bylaws. For purposes of this Agreement, “Material Adverse Effect” with respect to an entity means a material adverse effect on the assets, business, condition (financial or otherwise) or, results of operations or future prospects of such entity.

 

3


 

2.2 Capitalization . The authorized capital stock of the Company consists of  __________  Company Shares. As of the date of this Agreement,  _________  Company Shares will be issued and outstanding upon completion of all of the transactions described herein. There are no outstanding or authorized options, warrants, rights, agreements or commitments to which the Company is a party or which are binding upon the Company providing for the issuance or redemption of any of its capital stock. There are no outstanding or authorized stock appreciation, phantom stock or similar rights with respect to the Company. There are no agreements to which the Company is a party or by which it is bound with respect to the voting (including without limitation voting trusts or proxies), registration under the Securities Act, or sale or transfer (including without limitation agreements relating to pre-emptive rights, rights of first refusal, co-sale rights or “drag-along” rights) of any securities of the Company. All of the issued and outstanding Company Shares were issued in compliance with applicable federal and state securities laws.
2.3 Authorization of Transaction . Subject to approval of the Board of Directors which shall be prior to Closing, the Company has all requisite power and authority to execute and deliver this Agreement and to perform its obligations hereunder.
2.4 Noncontravention . Subject to the filing of the Certificate of Merger as required by the DGCL, neither the execution and delivery by the Company of this Agreement, nor the consummation by the Company of the transactions contemplated hereby, will (a) conflict with or violate any provision of the certificate of incorporation or bylaws of the Company, as amended to date, bylaws or other organizational document of any Subsidiary (as defined below), (b) require on the part of the Company or any Subsidiary any filing with, or any permit, authorization, consent or approval of, any court, arbitrational tribunal, administrative agency or commission or other governmental or regulatory authority or agency (a “Governmental Entity”), (c) conflict with, result in a breach of, constitute (with or without due notice or lapse of time or both) a default under, result in the acceleration of obligations under, create in any Party the right to terminate, modify or cancel, or require any notice, consent or waiver under, any contract or instrument to which the Company or any Subsidiary is a party or by which the Company or any Subsidiary is bound or to which any of their assets is subject, (d) result in the imposition of any mortgage, pledge, security interest, encumbrance, charge or other lien (whether arising by contract or by operation of law), (each, a “Security Interest”) upon any assets of the Company or any Subsidiary or (e) violate any order, writ, injunction, decree, statute, rule or regulation applicable to the Company, any Subsidiary or any of their properties or assets.
2.5 License Agreement . The License Agreement is legal, valid, binding and enforceable and in full force and effect; (ii) the agreement will continue to be legal, valid, binding and enforceable and in full force and effect immediately following the Closing in accordance with the terms thereof as in effect immediately prior to the Closing; and (iii) neither the Company nor any Subsidiary nor, to the knowledge of the Company, any other party, is in breach or violation of, or default under, any such agreement, and no event has occurred, is pending or, to the knowledge of the Company, is threatened, which, after the giving of notice, with lapse of time, or otherwise, would constitute a breach or default by the Company or any Subsidiary or, to the knowledge of the Company, any other party under such contract.
2.6 Litigation. There is no action, suit, proceeding, claim, arbitration or investigation before any Governmental Entity or before any arbitrator (a “Legal Proceeding”) that is pending or has been threatened in writing against the Company or any Subsidiary.
2.7 Disclosure . No representation or warranty by the Company contained in this Agreement, and no or any other document, certificate or other instrument delivered or to be delivered by or on behalf of the Company pursuant to this Agreement, contains or will contain any untrue statement of a material fact or omits or will omit to state any material fact necessary, in light of the circumstances under which it was or will be made, in order to make the statements herein or therein not misleading. The Company has disclosed to the Parent all material information relating to the business of the Company or any Subsidiary or the transactions contemplated by this Agreement.

 

4


 

ARTICLE III
REPRESENTATIONS AND WARRANTIES OF THE PARENT
AND THE ACQUISITION SUBSIDIARY
Each of the Parent and the Acquisition Company represents and warrants to the Company as follows:
3.1 Organization, Qualification and Corporate Power . The Parent is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware and the Acquisition Subsidiary is a corporation duly organized, validly existing and in good standing under the laws of the state of Delaware. The Parent is duly qualified to conduct business and is in good standing under the laws of each jurisdiction in which the nature of its businesses or the ownership or leasing of its properties requires such qualification, except where the failure to be so qualified or in good standing would not have a Material Adverse Effect. The Parent has all requisite corporate power and authority to carry on the businesses in which it is engaged and to own and use the properties owned and used by it. The Parent has furnished or made available to the Company complete and accurate copies of its certificate of incorporation and bylaws.
3.2 Capitalization . The authorized capital stock of the Parent consists of (a) 240,000,000 shares of Parent Common Stock, of which 58,232,591 shares were issued and outstanding as of the date of this Agreement, (b) 10,000,000 shares of preferred stock, $0.001 par value per share, of which no shares were issued and outstanding as of the date of this Agreement. All of the issued and outstanding shares of Parent Common Stock are duly authorized, validly issued, fully paid, nonassessable and free of all preemptive rights. All of the issued and outstanding shares of Parent Common Stock were issued in compliance with applicable federal and state securities laws. The shares to be issued at the Closing pursuant to Section 1.7 hereof shall be duly and validly issued, fully paid and nonassessable and free of all preemptive rights.
3.3 Authorization of Transaction . Subject to the approval of the Board of Directors of the Copoany which shall be delivered at Closing, each of the Parent and the Acquisition Subsidiary has all requisite power and authority to execute and deliver this Agreement and to perform its obligations hereunder.
3.4 Noncontravention . Subject to compliance with the applicable requirements of the Securities Act and any applicable state securities laws, and the filing of the Certificate of Merger as required by the DGCL, neither the execution and delivery by the Parent or the Acquisition Subsidiary of this Agreement or the Transaction Documentation, nor the consummation by the Parent or the Acquisition Subsidiary of the transactions contemplated hereby or thereby, will (a) conflict with or violate any provision of the certificate of incorporation or bylaws of the Parent or the Acquisition Subsidiary, (b) require on the part of the Parent or the Acquisition Subsidiary any filing with, or permit, authorization, consent or approval of, any Governmental Entity, (c) conflict with, result in breach of, constitute (with or without due notice or lapse of time or both) a default under, result in the acceleration of obligations under, create in any Party any right to terminate, modify or cancel, or require any notice, consent or waiver under, any contract or instrument to which the Parent or the Acquisition Subsidiary is a party or by which either is bound or to which any of their assets are subject, or (d) violate any order, writ, injunction, decree, statute, rule or regulation applicable to the Parent or the Acquisition Subsidiary or any of their properties or assets.
3.5 Subsidiary . The Acquisition Subsidiary was formed solely to effectuate the Merger, and has not conducted any business operations since its organization. The Parent has delivered or made available to the Company complete and accurate copies of the charter, bylaws or other organizational documents of the Acquisition Subsidiary. The Acquisition Subsidiary has no assets other than minimal paid-in capital, it has no liabilities or other obligations, and it is not in default under or in violation of any provision of its charter, bylaws or other organizational documents. All of the issued and outstanding shares of capital stock of the Acquisition Subsidiary are duly authorized, validly issued, fully paid, nonassessable and free of preemptive rights. All shares of the Acquisition Subsidiary are owned by Parent free and clear of any restrictions on transfer (other than restrictions under the Securities Act and state securities laws), claims, Security Interests, options, warrants, rights, contracts, calls, commitments, equities and demands. There are no voting trusts, proxies or other agreements or understandings with respect to the voting of any capital stock of the Acquisition Subsidiary.

 

5


 

3.6 Litigation . There is no Legal Proceeding which is pending or, to the Parent’s knowledge, threatened against the Parent or any subsidiary of the Parent.
3.7 Board Action . Prior to Closing, the Parent’s Board of Directors shall (a) unanimously determine that the Merger is advisable and in the best interests of the Parent’s stockholders and is on terms that are fair to such Parent stockholders and (b) cause the Parent, in its capacity as the sole stockholder of the Acquisition Subsidiary, and the Board of Directors of the Acquisition Subsidiary, to approve the Merger and this Agreement by written consent.
ARTICLE IV
COVENANTS
4.1 Closing Efforts . Each of the Parties shall use commercially reasonable efforts, to take all actions and to do all things necessary, proper or advisable to consummate the transactions contemplated by this Agreement, including without limitation using its commercially reasonable efforts to ensure that (i) its representations and warranties remain true and correct in all material respects through the Closing Date and (ii) the conditions to the obligations of the other Parties to consummate the Merger are satisfied.
4.2 Governmental and Third-Party Notices and Consents . Each Party shall use its commercially reasonable efforts to obtain, at its expense, all waivers, permits, consents, approvals or other authorizations from Governmental Entities, and to effect all registrations, filings and notices with or to Governmental Entities, as may be required for such Party to consummate the transactions contemplated by this Agreement and to otherwise comply with all applicable laws and regulations in connection with the consummation of the transactions contemplated by this Agreement.
4.3 Expenses . The costs and expenses (including legal fees and expenses) of Parent and the Acquisition Subsidiary incurred in connection with this Agreement and the transactions contemplated hereby shall be payable by and be the responsibility of the Parent prior to the Effective Time and Parent shall satisfy such obligations and liabilities prior to the Effective Time.
ARTICLE V
CONDITIONS TO CONSUMMATION OF MERGER
5.1 Conditions to Each Party’s Obligations . The respective obligations of each Party to consummate the Merger are subject to the satisfaction of the following conditions:
(a) this Agreement and the Merger shall have received the approval of the Company’s and the Parent’s Board of Directors;
(b) completion of a Consulting Agreement satisfactory to the Company and Anthony P. Noll.
5.2 Conditions to Obligations of the Parent and the Acquisition Subsidiary . The obligation of each of the Parent and the Acquisition Subsidiary to consummate the Merger is subject to the satisfaction (or waiver by the Parent) of the following additional conditions:
(a) the representations and warranties of the Company set forth in this Agreement shall be true and correct in all material respects as of the date of this Agreement and as of the Effective Time as though made as of the Effective Time;
(b) the Company and its Subsidiaries shall have obtained (and shall have provided copies thereof to the Parent) all of the waivers, permits, consents, approvals or other authorizations, and effected all of the registrations, filings and notices, referred to in Section 4.2 which are required on the part of the Company or the Subsidiaries, except for any the failure of which to obtain or effect would not, individually or in the aggregate, have a Company Material Adverse Effect or a material adverse effect on the ability of the Parties to consummate the transactions contemplated by this Agreement;

 

6


 

(c) no Legal Proceeding shall be pending wherein an unfavorable judgment, order, decree, stipulation or injunction would (i) prevent consummation of any of the transactions contemplated by this Agreement, (ii) cause any of the transactions contemplated by this Agreement to be rescinded following consummation or (iii) have, individually or in the aggregate, a Material Adverse Effect on the Company, and no such judgment, order, decree, stipulation or injunction shall be in effect; and
(d) the Company shall have delivered to the Parent and the Acquisition Subsidiary a certificate (the “Company Certificate”) to the effect that each of the conditions specified in Section 5.1 and Section 5.2 is satisfied in all respects.
5.3 Conditions to Obligations of the Company . The obligation of the Company to consummate the Merger is subject to the satisfaction of the following additional conditions:
(a) the representations and warranties of the Parent set forth in this Agreement shall be true and correct as of the date of this Agreement and shall be true and correct as of the Effective Time as though made as of the Effective Time;
(b) the Parent shall have obtained (and shall have provided copies thereof to the Company and its Subsidiaries) all of the waivers, permits, consents, approvals or other authorizations, and effected all of the registrations, filings and notices, referred to in Section 4.2 which are required on the part of the Parent, except for any the failure of which to obtain or effect would not, individually or in the aggregate, have a Parent Material Adverse Effect or a material adverse effect on the ability of the Parties to consummate the transactions contemplated by this Agreement;
(c) no Legal Proceeding shall be pending wherein an unfavorable judgment, order, decree, stipulation or injunction would (i) prevent consummation of any of the transactions contemplated by this Agreement, (ii) cause any of the transactions contemplated by this Agreement to be rescinded following consummation or (iii) have, individually or in the aggregate, an adverse effect on the Parent, and no such judgment, order, decree, stipulation or injunction shall be in effect; and
(d) the Parent shall have delivered to the Company a certificate (the “Parent Certificate”) to the effect that each of the conditions specified in Section 5.1 and this Section 5.3 is satisfied in all respects.
ARTICLE VII
TERMINATION
7.1 Termination by Mutual Agreement . This Agreement may be terminated at any time by mutual consent of the parties hereto, provided that such consent to terminate is in writing and is signed by each of the parties hereto.
7.2 Termination for Failure to Close . This Agreement shall be automatically terminated if the Closing Date shall not have occurred by July 28, 2009.
7.3 Termination by Operation of Law . This Agreement may be terminated by any Party hereto if there shall be any statute, rule or regulation that renders consummation of the transactions contemplated by this Agreement (the “Contemplated Transactions) illegal or otherwise prohibited, or a court of competent jurisdiction or any government (or governmental authority) shall have issued an order, decree or ruling, or has taken any other action restraining, enjoining or otherwise prohibiting the consummation of such transactions and such order, decree, ruling or other action shall have become final and nonappealable.
7.4 Effect of Termination or Default; Remedies . In the event of termination of this Agreement as set forth above, this Agreement shall forthwith become void and there shall be no liability on the part of any Party hereto, provided that such Party is a Non-Defaulting Party (as defined below). The foregoing shall not relieve any Party from liability for damages actually incurred as a result of such Party’s breach of any term or provision of this Agreement.

 

7


 

ARTICLE VIII
MISCELLANEOUS
8.1 Press Releases and Announcements . No Party shall issue any press release or public announcement relating to the subject matter of this Agreement without the prior written approval of the other Parties; provided, however, that any Party may make any public disclosure it believes in good faith is required by applicable law, regulation or stock market rule (in which case the disclosing Party shall use reasonable efforts to advise the other Parties and provide them with a copy of the proposed disclosure prior to making the disclosure).
8.2 No Third Party Beneficiaries . This Agreement shall not confer any rights or remedies upon any person other than the Parties and their respective successors and permitted assigns; provided, however, that (a) the provisions in Article I concerning issuance of the Merger Shares and Article VI concerning indemnification are intended for the benefit of the Company Stockholders and (b) the provisions in Section 4.9 concerning indemnification are intended for the benefit of the individuals specified therein and their successors and assigns.
8.3 Entire Agreement . This Agreement (including the documents referred to herein) constitutes the entire agreement among the Parties and supersedes any prior understandings, agreements or representations by or among the Parties, written or oral, with respect to the subject matter hereof.
8.4 Succession and Assignment . This Agreement shall be binding upon and inure to the benefit of the Parties named herein and their respective successors and permitted assigns. No Party may assign either this Agreement or any of its rights, interests or obligations hereunder without the prior written approval of the other Parties; provided that the Acquisition Subsidiary may assign its rights, interests and obligations hereunder to a wholly-owned subsidiary of the Parent.
8.5 Counterparts and Facsimile Signature . This Agreement may be executed in two or more counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument. This Agreement may be executed by facsimile signature.
8.6 Headings . The section headings contained in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement.
8.7 Notices . All notices, requests, demands, claims, and other communications hereunder shall be in writing. Any notice, request, demand, claim or other communication hereunder shall be deemed duly delivered four business days after it is sent by registered or certified mail, return receipt requested, postage prepaid, or one business day after it is sent for next business day delivery via a reputable nationwide overnight courier service, in each case to the intended recipient as set forth below:
If to Parent:
         
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
 
       
 
  Sauerwein, Simon, & Blanchard, P.C.    
 
  147 N. Meramec, Suite 200    
 
  St. Louis, MO 63105    
 
  Fax: 314.863.9101    
 
  Attn: Paul A. Simon, Esq.    

 

8


 

If to the Company:
         
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
Copy to (which copy shall not constitute notice hereunder):
         
 
 
 
   
 
 
 
   
 
 
 
   
 
 
 
   
Any Party may give any notice, request, demand, claim or other communication hereunder using any other means (including personal delivery, expedited courier, messenger service, telecopy, telex, ordinary mail or electronic mail), but no such notice, request, demand, claim or other communication shall be deemed to have been duly given unless and until it actually is received by the Party for whom it is intended. Any Party may change the address to which notices, requests, demands, claims, and other communications hereunder are to be delivered by giving the other Parties notice in the manner herein set forth.
8.8 Governing Law . This Agreement shall be governed by and construed in accordance with the internal laws of the State of Illinois without giving effect to any choice or conflict of law provision or rule (whether of the State of Illinois or any other jurisdiction) that would cause the application of laws of any jurisdictions other than those of the State of Illinois.
8.9 Amendments and Waivers . The Parties may mutually amend any provision of this Agreement at any time prior to the Effective Time. No amendment of any provision of this Agreement shall be valid unless the same shall be in writing and signed by all of the Parties. No waiver of any right or remedy hereunder shall be valid unless the same shall be in writing and signed by the Party giving such waiver. No waiver by any Party with respect to any default, misrepresentation or breach of warranty or covenant hereunder shall be deemed to extend to any prior or subsequent default, misrepresentation or breach of warranty or covenant hereunder or affect in any way any rights arising by virtue of any prior or subsequent such occurrence.
8.10 Severability . Any term or provision of this Agreement that is invalid or unenforceable in any situation in any jurisdiction shall not affect the validity or enforceability of the remaining terms and provisions hereof or the validity or enforceability of the offending term or provision in any other situation or in any other jurisdiction. If the final judgment of a court of competent jurisdiction declares that any term or provision hereof is invalid or unenforceable, the Parties agree that the court making the determination of invalidity or unenforceability shall have the power to limit the term or provision, to delete specific words or phrases, or to replace any invalid or unenforceable term or provision with a term or provision that is valid and enforceable and that comes closest to expressing the intention of the invalid or unenforceable term or provision, and this Agreement shall be enforceable as so modified.
8.11 Construction .
(a) The language used in this Agreement shall be deemed to be the language chosen by the Parties to express their mutual intent, and no rule of strict construction shall be applied against any Party.
(b) Any reference to any federal, state, local or foreign statute or law shall be deemed also to refer to all rules and regulations promulgated thereunder, unless the context requires otherwise.

 

9


 

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the date first above written.
             
    PARENT    
    CLEANTECH BIOFUELS, INC.    
 
           
 
  By:        
 
  Name:  
 
   
 
  Title:  
 
President and Chief Executive Officer
   
 
           
    ACQUISITION SUBSIDIARY    
    BIOMASS NA ACQUISITION SUBISIDARY, INC.    
 
           
 
  By:        
 
  Name:  
 
   
 
  Title:  
 
President and Chief Executive Officer
   
 
           
    COMPANY    
    BIOMASS NORTH AMERICA LICENSING, INC.    
 
           
 
  By:        
 
  Name:  
 
   
 
  Title:  
 
President and Chief Executive Officer
   

 

10

Exhibit 31.1
CERTIFICATION
I, Edward P. Hennessey, Jr., certify that:
1. I have reviewed this quarterly report on Form 10-Q of CleanTech Biofuels, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
         
Dated: August 13, 2008
  /s/ Edward P. Hennessey, Jr.
 
Edward P. Hennessey, Jr.
   
 
  Chief Executive Officer    

 

 

Exhibit 31.2
CERTIFICATION
I, Thomas Jennewein, certify that:
1. I have reviewed this quarterly report on Form 10-Q of CleanTech Biofuels, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c. Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d. Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
         
Dated: August 13, 2008
  /s/ Thomas Jennewein
 
Thomas Jennewein
   
 
  Chief Accounting Officer    

 

 

Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of CleanTech Biofuels, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2008, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Edward P. Hennessey, Jr., Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
  1)  
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
  2)  
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
Dated: August 13, 2008
  /s/ Edward P. Hennessey, Jr.
 
Edward P. Hennessey, Jr.
   
 
  Chief Executive Officer    
This certification is made solely for purposes of 18 U.S.C. Section 1350 and not for any other purpose.

 

 

Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT
TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of CleanTech Biofuels, Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2008, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Thomas Jennewein, Chief Accounting Officer of the Company, certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
  1)  
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
  2)  
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
         
Dated: August 13, 2008
  /s/ Thomas Jennewein
 
Thomas Jennewein
   
 
  Chief Accounting Officer    
This certification is made solely for purposes of 18 U.S.C. Section 1350 and not for any other purpose.